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Abstract  
Subjective quality of life (SQOL) is an important outcome in the treatment of patients with 
schizophrenia.  However, there is only limited evidence on factors influencing SQOL, and 
little is known about whether the same factors influence SQOL in patients with schizophrenia 
and other mental disorders. This study aimed to identify factors associated with SQOL and 
test whether these factors are equally important in schizophrenia and other disorders. For this 
we used a pooled data set obtained from 16 studies that had used either the Lancashire Quality 
of Life Profile or the Manchester Short Assessment of Quality of Life for assessing SQOL.  
The sample comprised 3936 patients with schizophrenia, mood disorders, and neurotic 
disorders.  After controlling for confounding factors, within-subject clustering, and 
heterogeneity of findings across studies in linear mixed models, patients with schizophrenia 
had more favourable SQOL scores than those with mood and neurotic disorders. In all 
diagnostic groups, older patients, those in employment, and those with lower symptom scores 
had higher SQOL scores. Whilst the strength of the association between age and SQOL did 
not differ across diagnostic groups, symptom levels were more strongly associated with 
SQOL in neurotic than in mood disorders and schizophrenia. The association of employment 
and SQOL was stronger in mood and neurotic disorders than in schizophrenia. The findings 
may inform the use and interpretation of SQOL data for patients with schizophrenia. 
 
Key words: quality of life, outcomes, schizophrenia, psychopathology 
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1. Introduction 
Subjective quality of life (SQOL) is an established patient-reported outcome in schizophrenia 
(Priebe and Fakhoury, 2008). Whilst there is no consensus on its precise definition, several 
scales are based on Lehman’s (Lehman, 1996) approach of measuring SQOL as satisfaction 
with life in general and major life domains.  
 
In research studies and evaluation of routine care, socio-demographic and clinical factors that 
may influence scores must be considered (Priebe and Fakhoury, 2008). Socio-demographic 
factors frequently studied are age (e.g. Sullivan et al., 1991; Sullivan et al., 1992), gender (e.g. 
Lehman et al., 1995; Roeder-Wanner et al., 1997), marital status (e.g. Mares et al., 2002; 
Marwaha et al., 2008), level of education (e.g. Caron et al., 2005; Swanson et al., 1998), and 
employment status (e.g. Marwaha and Johnson, 2004; Priebe et al., 1998).  Significant 
associations are reported for some of these variables with SQOL, mostly indicating that older 
age, better education, and employment are linked with more favourable SQOL (e.g. Evans et 
al., 2000; Gaite et al., 2002; Marwaha et al., 2008). A recent meta-analysis (Vatne and 
Bjorkly, 2008) however failed to find robust evidence that socio-demographic factors 
influenced SQOL. More consistent evidence associates higher symptom levels with poorer 
SQOL (e.g. Huppert et al., 2001; Kasckow et al., 2001; Marwaha et al., 2008; Priebe et al., 
2000).  A meta-analysis (Eack and Newhill, 2007) found weak correlations between symptom 
levels and SQOL with a substantial heterogeneity.  
 
Initially, SQOL measures were used in psychiatry predominantly in samples with severe 
mental illnesses, mainly schizophrenia, but interest has increased in other diagnostic groups 
(d'Ardenne et al., 2005; Rakib et al., 2005; Rudolf and Priebe, 1999).  Differences in SQOL 
between patients with schizophrenia and those with mood disorders are inconsistent 
(Atkinson et al., 1997; Ruggeri et al., 2002; Vatne and Bjorkly, 2008).  Similar socio-
demographic and clinical factors were suggested as influencing SQOL in patients with 
schizophrenia and other diagnostic groups. However, the question as to whether the same 
factors influence SQOL in different diagnostic groups has not been systematically 
investigated.  
 
Using a pooled analysis with data from several studies, we aimed to identify factors 
influencing SQOL and test whether they differed between patients with schizophrenia and 
those with other mental disorders. A pooled analysis considers both studies and individual 
patients as the unit of analysis and has several advantages as compared to a conventional 
meta-analysis: it enables a more precise estimate of effects of a influential factor;  allows for 
controlling of confounding factors including within-subject clustering and heterogeneity 
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across studies at the patient level; reduces effects of heterogeneity from aggregation of 
methodologically diverse studies by using the same statistical model; and permits testing main 
effects as well as interactions essential for exploring whether factors have similar influences 
in patients with schizophrenia and other diagnostic groups (Blettner et al., 1999; Reininghaus 
and Priebe, 2007). 
 
2. Materials and methods 
In a pooled analysis, linear mixed models were applied to individual patient-level data from 
samples of patients with schizophrenia, mood disorders, and neurotic disorders, with SQOL 
as the dependent variable.  
 
2.1 Sample 
The pooled data set was collected specifically for the current study. Given the heterogeneity 
of measurement methods (Vatne and Bjorkly, 2008), only data sets using the Lancashire 
Quality of Life Profile (LQOLP) (Oliver et al., 1997) or its short version, the Manchester 
Short Assessment of Quality of Life (MANSA) (Priebe et al., 1999) were included . To 
identify relevant data sets we contacted experts in the field and conducted a literature search 
of academic databases. 
 
We aimed to use diagnostic categories with sufficient sample sizes of each category in the 
complex analysis. We therefore included only patients with documented diagnoses of 
schizophrenia, schizotypal, or delusional disorders (F2), mood disorders (F3), or neurotic, 
stress-related, and somatoform disorders (F4) according to ICD-10 (World Health 
Organization, 1993). Patients with less frequent and unclear diagnoses were excluded. If 
available, another SQOL assessment, obtained for the same patients at a later point of time, 
was included.  These increased precision of estimates of effects by increasing the number of 
observations whilst controlling for confounding by within-subject clustering. For studies with 
more than two time points the first and last one were used to achieve longest and similar times 
between measurements.  
 
2.2 Measures 
Included studies used either the LQOLP or MANSA for measuring SQOL, both of which use 
Lehman’s approach (Lehman, 1996).  LQOLP and MANSA contain items on satisfaction 
with life in general and different life domains rated from 1 (couldn’t be worse) to 7 (couldn’t 
be better).  They have been shown to yield practically identical SQOL scores with a 
correlation between LQOLP and MANSA mean scores of r = .94 (Priebe et al., 1999). and are 
widely used in mental health service research in Europe. Their reliability and validity has 
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been demonstrated in several studies (Gaite et al., 2000; Kaiser et al., 1997; Kaiser and 
Priebe, 1998; Nieuwenhuizen et al., 2001; Priebe et al., 1999; Ruggeri et al., 2001). Limiting 
to these two measures ensures consistent data and fully utilises the advantages of a pooled 
analysis.  
 
Consistent information was available for the following socio-demographic and clinical 
characteristics hypothesized to influence SQOL:  age, gender, marital status (married / 
partnership, other), level of education (school level, further education,  higher education; the 
exact definitions varied according to national education systems; school level usually means 
completion of 10 years of school education, equivalent to 2 years of high school in the US), 
employment status (unemployed, other), current treatment (inpatient, outpatient), clinical 
diagnosis, and level of psychiatric symptoms.  In the majority of studies (n=13), symptoms 
were assessed on the Positive and Negative Syndrome Scale (PANSS) (Kay et al., 1987) or 
Brief Psychiatric Rating Scale (BPRS) (Overall and Gorham, 1988).  This allowed for 
computing BPRS-18 total scores and scores of five BPRS-18 subscales: anxiety/depression, 
anergia, thought disorder, activity, and hostility. 
 
2.3 Statistical Analysis 
Stata 10 for Windows was used for all data analyses (Stata, 2007).  Linear mixed models were 
used to identify factors associated with subjective quality of life in different diagnostic groups 
whilst controlling for confounding factors, within-subject clustering of paired measurements 
and heterogeneity across studies using xtmixed and gllamm in Stata 10 (Rabe-Hesketh et 
al., 2002; Stata, 2007).  In this three-level model, paired measurements (level-1) were treated 
as nested within patients (level-2), and patients nested within studies (level-3).  Observations 
at level-1 were assumed to be missing at random.  The modelling for identifying factors 
influencing SQOL proceeded through three stages.  (1) Mixed models were fitted with SQOL 
scores as dependent variable and fixed effects adjusted for the time of measurement for the 
following set of independent variables: age, gender, marital status, level of education, 
employment status, type of current treatment, ICD-10 clinical diagnosis, and symptom level.  
(2) All fixed effects identified as statistically significant in stage (1) were entered into a 
multivariate mixed model adjusted for time point, country of residence, and time to follow-up 
as a priori confounders.  (3) Two-way interaction terms for significant fixed effects x 
diagnosis were added one by one to the multivariate mixed model to establish whether the 
effects of factors influencing SQOL identified in stage 2 differed across diagnostic groups.  
Statistical significance of interaction terms was assessed using likelihood ratio tests to 
evaluate improvement of model fit.  In all stages, heterogeneity of findings across the 
included study samples was controlled for using likelihood ratios to assess whether adding a 
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random slope for average / proportional patient characteristics (mean age per study, 
proportion female per study, proportion educated to school  level per study, proportion 
married/partnership per study, proportion unemployed per study, proportion in outpatient care 
per study, proportion with schizophrenia, and mean BPRS-18 symptom level) and study 
characteristics, i.e. study design (cross-sectional design, prospective-observational design vs. 
RCTs) and sample size (small vs. large sample sizes (i.e. ≤ 100) (Higgins and Green, 2008)). 
 
 
3. Results 
 
3.1 Included studies and samples 
Sixteen studies (Burns et al., 1999; d'Ardenne et al., 2005; Eklund et al., 2001; Hansson et al., 
1999; Hansson et al., 2007; Kallert et al., 2007; McCabe and Priebe, 2004; McGuire-Snieckus 
et al., 2007; Priebe et al., 2002a; Priebe et al., 2002b; Priebe et al., 2007; Rakib et al., 2005; 
Roeder-Wanner and Priebe, 1998; Ruggeri et al., 2002; Slade et al., 2006), including one 
unpublished study (Junghan et al. 2009, unpublished data), were included (see Table 1). 
Twelve were observational, six each cross-sectional and longitudinal, and four randomized 
controlled trials (RCTs).   
 
Insert Table 1 about here 
 
From these 16 studies, single SQOL mean scores were available for a total of 3936 patients 
with schizophrenia, schizotypal, or delusional disorders (F2, n = 2393), mood disorders (F3, n 
= 651), or neurotic, stress-related and somatoform disorders (F4, n = 892). Paired assessments 
with SQOL at two time points were available from 2196 patients in 10 studies, the mean 
duration between measurements being 17.5 months (SD = 8.1).   
 
 
3.2 Patient characteristics 
Patient characteristics for the three diagnostic groups are shown in Table 2. 
 
Insert Table 2 about here 
 
The mean age of patients was 40.7 years with a roughly equal gender distribution.  About half 
of the patients were unemployed.  Most patients were unmarried or not living in partnership, 
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being treated as outpatients, and had been diagnosed with schizophrenia.  Mean symptom 
levels were mild to moderate.   
 
3.3 Factors associated with SQOL 
Associations of potentially influential factors and SQOL as a dependent variable controlling 
for time point, within-subject clustering and heterogeneity of findings across studies are 
shown in Table 3.   
 
Insert Table 3 about here 
 
Almost all variables were significantly associated with SQOL apart from gender, level of 
education, and service setting. There was a significant heterogeneity across studies for marital 
status and sample size. 
 
Table 4 shows multivariate mixed models analysis for potential influential factors and SQOL 
as dependent variable. 
 
Insert Table 4 about here 
 
In this step of the analysis, age, employment status, diagnosis, and BPRS total and subscale 
scores were significantly and independently associated with SQOL. Older patients, those in 
employment, with schizophrenia and with lower symptom levels had significantly higher 
SQOL scores. All BPRS subscales were significantly associated with SQOL scores. No 
significant heterogeneity of findings across studies was found.  
 
3.4 Factors influencing SQOL in patients with schizophrenia and other disorders 
Interaction effects of diagnosis and factors identified as significantly associated with SQOL in 
the previous multivariate mixed model are summarised in Table 5. 
 
Insert Table 5 about here 
 
A likelihood ratio test showed an equally strong association of age with SQOL in all 
diagnostic groups (χ2 = 1.98, P=.371).  There was a significant interaction for diagnosis by 
employment status (χ2 = 11.1, P = .004), with unemployment effects being significantly 
weaker in schizophrenia patients than in mood disorders and neurotic disorders.   
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Symptom levels were inversely related to SQOL in patients with schizophrenia, mood 
disorders, and neurotic disorders.  There was a significant interaction effect for diagnosis by 
symptoms levels (χ2 = 6.86, P = .032).  While higher symptom levels were associated with 
lower SQOL in patients of all diagnostic groups, the influence of symptom levels was 
significantly stronger in patients with neurotic disorders than in those with schizophrenia and 
mood disorders.  There were no significant interaction effects for diagnosis by BPRS-18 
subscales.   
 
 
4. Discussion 
 
4.1 Main findings 
The pooled analysis found more favourable SQOL scores in patients with schizophrenia than 
with other diagnoses. It showed higher SQOL scores in older patients, those in employment 
and those with lower symptom levels. However, the influence of factors other than age varied 
across diagnostic groups. The association of symptoms with SQOL was significantly stronger 
in neurotic patients than in schizophrenia and mood disorders.  The influence of employment 
was significantly stronger in mood and neurotic disorders than in schizophrenia.   
 
4.2 Strengths and limitations 
This is the largest study to date using a pooled data set to analyse factors influencing SQOL in 
patients with schizophrenia and other mental disorders. The analysis considered both studies 
and individual patients as units of analysis. Overcoming some of the limitations of 
conventional meta-analytic techniques, the study therefore complements meta-analytical 
findings. Further strengths are that the sample size was sufficiently large for this type of 
complex analysis (although it varied for different analyses in this study), and that for the 
majority of patients the analysis included two assessments at different time points. This 
increased the precision of the findings whilst controlling for within-subject clustering. SQOL 
data and other characteristics were assessed with very similar methods and categories across 
all included data sets, excluding potential inconsistencies of assessment methods as a source 
of heterogeneity. 
 
The study has five major limitations: A) We included only studies using the LQOLP and 
MANSA. B) Study patients were not representative of all patients in the given service. 
Selection biases might have influenced SQOL levels in diagnostic groups. C) The number of 
factors in the analysis was limited. Potential factors such as length of illness or details of 
current treatment (might have explained the differences found between groups) were not 
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considered. D) Only crude categories of each variable were analysed. E) The diagnostic 
procedures were not consistently standardised across all studies.  
 
4.3 Comparisons with previous research 
In this analysis schizophrenia patients had more positive SQOL scores than other diagnoses. 
This is not accounted for by differences in socio-demographics or symptom levels. Perhaps 
schizophrenia patients adapt to the experience of living with their disorder in different ways 
than patients with other disorders (Atkinson et al., 1997; Lehman, 1996). They might have 
lowered their expectations leading to a higher satisfaction, found more appropriate methods to 
achieve satisfaction in difficult circumstances, or be less prone to rate items in questionnaires 
based on negative emotions. The difference may also reflect schizophrenia-specific clinical 
characteristics. Emotional withdrawal, affective blunting or cognitive deficits may limit the 
impact of higher symptom levels and disorder-related dysfunction on SQOL (Atkinson et al., 
1997), so that SQOL ratings are higher and the influence of overall symptoms lower than in 
patients with neurotic disorders. 
 
Despite the differences between diagnostic groups, higher levels of symptoms overall and of 
symptom subscales were associated with lower SQOL in all groups. This general association 
of symptom levels and SQOL is in line with previous research (Eack and Newhill, 2007). 
Based on our findings, an increase of BPRS total scores of 8.1 (i.e. 1 standard deviation), 
corresponds to a decrease in SQOL mean scores of .23 in patients with schizophrenia (i.e. 
using the standardised coefficient in Table 4 and a standard deviation of .98), .25 in patients 
with mood disorders, and .42 in patients with neurotic disorders. Hence, the association of 
overall symptom levels with SQOL appears clinically relevant.  
 
When other factors were adjusted for, marital status did not affect SQOL, which is consistent 
with Vatne and Bjoerkly’s meta-analysis (Vatne and Bjorkly, 2008). It may be possible that 
positive and negative effects of living with a partner cancel each other out. Younger age and 
unemployment were associated with lower SQOL, consistent with previous research. The 
influence of unemployment was weaker in schizophrenia patients, again possibly linked to 
lower expectations or disorder specific cognitive and emotional processes of appraising an 
adverse objective situation. It might also be possible that patients with schizophrenia more 
often have low paying and menial jobs and that such jobs lead to less improvement of SQOL 
than potentially more attractive jobs of patients in other diagnostic groups.  
 
The pooled analysis reduced the effect of the heterogeneity of findings across studies by using 
the same statistical model. In the final model significant heterogeneity was identified only for 
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diagnostic group.  The sensitivity analysis explained this heterogeneity by the absence of 
significant differences between diagnostic groups in studies with small sample sizes. Studies 
with small sample sizes may underestimate differences between diagnostic groups, whilst the 
study design does not make a difference.  
 
4.4 Implications 
The factors identified as associated with SQOL explain only small amounts of variance. 
Whether such variance is important or not, is likely to depend on the type of intervention to be 
evaluated and the purpose of a study. Small differences in SQOL as an outcome can be very 
relevant in studies testing inexpensive interventions which can easily be rolled out across 
services (Priebe et al., 2007), or in evaluations of services in large populations. In such 
studies, analyses may adjust for the influence of the factors identified in this analysis. The 
factors may also inform the allocation strategy in experimental studies, e.g. stratifying a 
random allocation by age, employment status, diagnostic group and/or symptom level. In 
studies that aim to identify large effect sizes in SQOL the associations with influential factors 
reported in this analysis may be less relevant.  
 
The analysis identified factors influencing SQOL in mostly observational designs. Based on 
this analysis alone, no firm conclusions can be drawn about possible interventions for 
improving SQOL. The literature suggests that symptom improvement and employment 
schemes can lead to improvements of SQOL (Burns et al., 2007; Leucht et al., 2003). Our 
findings would suggest that such an effect may be smaller in patients with schizophrenia than 
in neurotic disorders, given the differing influence of symptoms and employment status on 
SQOL between diagnostic groups. In any case the study can be used to estimate the gains in 
SQOL that may be expected in case of defined improvements of symptom levels. Moreover, 
the findings suggest that such estimates should be specific for different diagnostic groups and 
that not all findings of SQOL research can be generalised from one diagnostic group to others.  
 
Considering the higher SQOL in patients with schizophrenia further improvements through 
therapeutic interventions may be more difficult to achieve, and a potential ceiling effect must 
be considered. Studies of interventions to improve SQOL in schizophrenia patients might 
more profitably focus on patients with lower SQOL baseline scores as including patients with 
relatively positive SQOLs may obscure significant effects.  
 
More specific research including qualitative studies may explore why patients with 
schizophrenia have more positive SQOL than other diagnostic groups, and why their ratings 
are less influenced by symptoms and employment status. 
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Tables 
 
Table 1. Study characteristics of the 16 included studies and samples 
Study Country Sample size
1
  
(ICD-10: F2/F3/F4)  
Research 
design 
SQOL 
Measure
2
 
SQOL 
(baseline) 
  n   mean (SD) 
Roeder-Wanner & 
Priebe (1998) 
Germany 89  
(89/0/0) 
Prospective-
observational 
LQOLP 4.52 (.75) 
Burns et al. (1999)  UK 676  
(627/49/0) 
RCT LQOLP 4.25 (.74) 
Hansson et al. (1999) Sweden, Denmark, 
Finland, Norway, 
Iceland 
341  
(341/0/0) 
Cross-
sectional 
LQOLP 4.69 (.75) 
Eklund et al. (2001) Sweden 74  
(74/0/0) 
Cross-
sectional 
LQOLP 4.23 (.72) 
Priebe et al. (2002a) Croatia, Serbia, 
Bosnia 
440  
(0/0/440) 
Prospective-
observational 
MANSA 3.44 (.81) 
Ruggeri et al. (2002) Italy 300  
(103/108/89) 
Prospective-
observational 
LQOLP 4.57 (.90) 
Priebe et al. (2002b) Germany 100  
(100/0/0) 
Prospective-
observational 
LQOLP 4.65 (.79) 
McCabe & Priebe 
(2004) 
UK 124  
(124/0/0) 
Cross-
sectional 
MANSA 4.43 (.85) 
d’Ardenne et al. 
(2005) 
UK 105  
(0/21/84) 
Cross-
sectional 
MANSA 3.13 (.85) 
Rakib et al. (2005) UK 69  
(0/0/69) 
Cross-
sectional 
MANSA 4.11 (.69) 
Slade et al.(2006) UK 97  
(51/46/0) 
RCT MANSA 4.25 (1.00) 
Priebe et al. (2007) UK, Spain, 
Netherlands, 
Sweden, Germany, 
Switzerland 
447  
(447/0/0) 
RCT MANSA 4.70 (.88) 
Hansson et al. (2007) Sweden 
 
92  
(60/20/12) 
Prospective-
observational 
LQOLP 4.33 (.77) 
McGuire-Snieckus et 
al. (2007) 
UK 106  
(62/43/1) 
Cross-
sectional 
MANSA 5.12 (1.39) 
Kallert et al. (2007) Germany, UK, 
Poland, Slovakia, 
Czech Republic 
780  
(237/350/193) 
RCT MANSA 3.96 (.92) 
Junghan (unpublished 
data) 
Switzerland 96  
(78/14/4) 
Prospective-
observational 
LQOLP 4.72 (1.11) 
1 Sample size refers to included patients with an ICD-10 clinical diagnosis of schizophrenia, schizotypal, or delusional disorders, 
mood disorders, or neurotic, stress-related and somatoform disorders for which single SQOL mean scores were available 
2 LQOLP, Lancashire Quality of Life Profile; MANSA, Manchester Short Assessment of Quality of Life  
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Table 2.  Patient characteristics by diagnostic group 
 
ICD-10 clinical diagnosis (n (%)) 
Total sample 
(n=3936) Schizophrenia 
(n=2393) 
Mood disorders 
(n=651) 
Neurotic disorders 
(n=892) 
Age, mean (s.d.) 39.4 (11.4) 43.6 (12.7) 42.1 (11.6) 40.7 (11.8) 
Female, n(%) 993 (41.5) 425 (65.3) 366 (41.0) 1784 (45.3) 
Educated to school level, n(%) 806 (33.7) 244 (37.5) 146 (16.4) 1196 (30.4) 
Married/partnership, n(%) 292 (12.2) 270 (41.5) 479 (53.7) 1041 (26.5) 
Unemployed, n(%) 1388 (58.0) 207 (31.8) 257 (28.8) 1852 (47.1) 
Outpatient care, n(%) 1632 (68.2) 259 (41.3) 695 (77.9) 2596 (66.0) 
BPRS-18 total score, mean (s.d.) 37.6 (11.3) 35.0 (8.7) 33.0 (7.5) 36.5 (10.5) 
 Depression`/anxiety subscale, mean (s.d.) 9.9 (3.9) 13.9 (4.2) 13.2 (3.7) 10.8 (4.4) 
 Anergia subscale, mean (s.d.) 8.6 (3.6) 7.0 (2.8) 5.6 (2.2) 7.7 (3.5) 
 Thought disorder subscale, mean (s.d.) 8.6 (4.1) 5.2 (2.3) 4.6 (1.4) 7.3 (3.9) 
 Activation subscale, mean (s.d.) 5.7 (2.5) 4.7 (1.7) 4.8 (1.7) 5.2 (2.3) 
 Hostility subscale, mean (s.d.) 6.0 (2.8) 4.9 (2.2) 4.8 (2.0) 5.5 (2.6) 
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Table 3. Univariate mixed models analysis
a
 of potential influential factors and SQOL as dependent variable
 
Influential factor 
Total 
studies 
n 
Fixed part 
 
Random part
 
Heterogeneity  
(average patient 
characteristics)
b 
Standardized 
Beta  
Unstandardized Beta 
(95% CI) 
P 
Level-1 
residual 
variance 
Level-2 
random 
intercept 
variance 
Level-3 
random 
intercept 
variance
 
Level-3 
random 
slope 
variance
 
Age 15 3806 .04 .003 (.001 to .006) .004  .331 .400 .195 - χ2 = .26, P = .876d 
Female vs. male 16 3928 .02 .02 (-.03 to .07) .436  .334 .422 .222 - χ2 = 4.36, P = .113e 
Level of education 10 2303   .606  .353 .387 .060 - 
χ2 = .97, P = .614f  To school vs. further level   .04 .04 (-.04 to .12) .322      
 To school vs. higher level   .03 .03 (-.08 to .13) .611      
Married/partnership vs. other 12 3493 -.18 .06 (.03 to .09) <.001  .350 .411 .145 .051 χ2 = 11.71, P = .003g 
Unemployed vs. other 15 3771 -.32 -.32 (-.38 to -.25) <.001  .334 .402 .278 - χ2 = 4.58, P = .101h 
Outpatient vs. inpatient care 16 3936 .05 .05 (-.07 to .17) .441  .334 .236 .422 - χ2 = .86, P = .650i 
ICD-10 clinical diagnosis 16 3936   <.001  .334 .419 .198 - 
χ2 = 1.55, P < .462j  
Mood disorders vs. 
Schizophrenia 
  -.22 -.21 (-.30 to -.12) <.001      
 
Neurotic disorders vs. 
Schizophrenia 
  -.16 -.15 (-.27 to -.04) .008      
BPRS-18 total score 11 2397 -.28 -.027 (-.030 to -.023) <.001  .359 .414 .088 - χ2 = .30, P = .863k 
 Depression /anxiety subscale 11 2397 -.371 -.083 (-.091 to -.075) <.001  .358 .381 .046 - χ2 = .80, P = .671k 
 Anergia subscale 11 2397 -.07 -.02 (-.03 to -.01) <.001  .361 .472 .142 - χ2 = 4.74, P = .094k 
 Thought disorder subscale 11 2397 -.11 -.03 (-.04 to -.02) <.001  .361 .467 .010 - χ2 = 3.99, P = .136k 
 Activation subscale 11 2397 -.08 -.03 (-.05 to -.02) <.001  .361 .472 .085 - χ2 = 1.82, P = .403k 
 Hostility subscale 11 2397 -.21 -.08 (-.09 to -.07) <.001  .360 .440 .093 - χ2 = 1.86, P = .394k 
a Three-level random intercept and random coefficient models were used, treating measurement occasions (level-1) as nested within patients (level-2), and patients nested within studies (level-3); Estimates are adjusted 
for time point 
b Heterogeneity of findings across studies was tested using likelihood ratio tests to assess whether inclusion of random slopes for respective average patient characteristics at the study level (i.e. mean age per studyd, 
proportion female per studye, proportion educated to school  level per studyf, proportion married/partnership per studyg, proportion unemployed per studyh, proportion in outpatient care per studyi, proportion with 
schizophreniaj, mean BPRS-18 symptom levelk) improved model fit.  Inclusion of random slopes for study characteristics (study design, χ2 = 3.93, P = .140; sample size, χ2 = 7.82, P = .020) was also tested. Random 
slopes were not included when likelihood ratio tests were not significant. 
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Table 4. Multivariate mixed models analysis of potential influential factors and SQOL as dependent variable (8 studies, 2063 patients)
a 
Influential factor 
Fixed part 
 
Random part
b 
Heterogeneity 
(average patient 
characteristics)
b 
Standardized 
beta 
Unstandardized beta 
(95% CI) 
P 
Level-1 
residual 
variance 
Level-2 random 
intercept 
variance 
Level-3 random 
intercept 
variance
 
     .597 .421 .423  
Age .067 .006 (.003 to .009) <.001     - 
Married/partnership vs. other .07 .07 (-.02 to .15) .129     χ2 = 0.00, P = 1.00 
Unemployed vs. other -.18 -.18 (-.26 to -.10) <.001     - 
ICD-10 clinical diagnosis        
-  Mood disorders vs. Schizophrenia -.49 -.47 (-.58 to -.37) <.001     
 Neurotic disorders vs. Schizophrenia -.43 -.42 (-.54 to -.30) <.001     
BPRS-18 total score -.250 -.024 (-.027 to -.020) <.001     - 
 Depression / anxiety subscale -.35 -.08 (-.09 to -.07) <.001  .597 .401 .403 - 
 Anergia subscale -.06 -.02 (-.03 to -.01) .003  .598 .448 .447 - 
 Thought disorder subscale -.10 -.03 (-.04 to -.02) <.001  .598 .444 .445 - 
 Activation subscale -.05 -.02 (-.04 to -.01) .007  .598 .447 .448 - 
 Hostility subscale -.19 -.07 (-.09 to -.06) <.001  .598 .431 .431 - 
a Estimates are adjusted for time point, country of residence, and time to follow-up 
b Heterogeneity of findings across studies was tested using likelihood ratio tests to assess whether inclusion of random slopes for respective average patient characteristics at the study level (i.e. proportion 
married/partnership per studyc improved model fit if there was evidence of heterogeneity in univariate mixed models analysis (see Table 2).  Inclusion of random slopes for study characteristics (sample size, χ2 = .00, P 
= 1.00) was also tested. Random slopes were not included into the model when likelihood ratio tests were not significant. 
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Table 5. Multivariate mixed models analysis of factors influencing SQOL in schizophrenia, mood disorders, and neurotic disorders (8 studies, 2063 patients)
a
 
Influential factor 
Fixed part 
 
Random part
b 
Standardized 
beta 
Unstandardized beta 
(95% CI) 
P 
Level-1 residual 
variance 
Level-2 random 
intercept variance 
Level-3 random 
intercept variance
 
ICD-10 clinical diagnosis x employment status     .597 .420 .421 
 Unemployed vs. other        
  Schizophrenia -.11 -.10 (-.20 to -.01) .028     
  Mood disorders -.83 -.80 (-.97 to -.63) <.001     
  Neurotic disorders -.66 -.65 (-.85 to -.44) <.001     
ICD-10 clinical diagnosis x BPRS-18 total score     .597 .420 .422 
 Schizophrenia -.24 -.022 (-.026 to -.018) <.001     
 Mood disorders -.25 -.024 (-.033 to -.015) <.001     
 Neurotic disorders -.43 -.041 (-.054 to -.028) <.001     
a Interaction terms were added to the previous adjusted multivariate mixed model using a likelihood ratio test for assessing their statistical significance (diagnosis x employment status, χ2 = 11.1, P = .004; diagnosis x 
BPRS-18 total score, χ2 = 6.86, P = .032). Interaction terms did not significantly improve model fit for diagnosis x age (χ2 = 1.98, P = .371), BPRS-18 depression/anxiety subscale (χ2 = 4.56, P = .102), BPRS-18 anergia 
subscale (χ2 = 2.06, P = .357), BPRS-18 thought disorder subscale (χ2 = 3.30, P = .192), BPRS-18 activation subscale (χ2 = 2.11, P = .348), BPRS-18 hostility subscale (χ2 = .08, P = .962). 
b Heterogeneity of findings on interaction terms across studies was tested using likelihood ratio tests to assess whether inclusion of random slopes improved model fit if there was evidence of  
heterogeneity in previous multivariate mixed models analysis (see Table 3).  Random slopes were not included into the model when likelihood ratio tests were not significant. 
 
 
 
 
 
